Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: Case study from the WHO Drug Injection Study Phase II

BMC Public Health

Volumn 6, Issue , 2006, Pages

  Des Jarlais, Don C ^a,b   Perlis, Theresa E ^a,b   Stimson, Gerry V ^c,d   Poznyak, Vladimir ^e  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^c HARM REDUCTION INTERNATIONAL   (United Kingdom)

^d Charing Cross Campus   (United Kingdom)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COUNSELING; DRUG ABUSE; DRUG USE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; METHODOLOGY; PRACTICE GUIDELINE; RISK ASSESSMENT; SEROPREVALENCE; STANDARDIZATION; STRUCTURED QUESTIONNAIRE; WORLD HEALTH ORGANIZATION; ADULT; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CLINICAL PROTOCOL; DEVELOPING COUNTRY; FEMALE; HEALTH SERVICES RESEARCH; HIGH RISK BEHAVIOR; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERNATIONAL COOPERATION; MALE; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POPULATION DYNAMICS; PROCEDURES; PROGRAM DEVELOPMENT; PSYCHOLOGY; QUALITY CONTROL; QUESTIONNAIRE; SUBSTANCE ABUSE; VIROLOGY;

ADULT; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CLINICAL PROTOCOLS; CLINICAL TRIALS, PHASE II AS TOPIC; DEVELOPING COUNTRIES; FEMALE; GUIDELINES AS TOPIC; HEALTH TRANSITION; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INTERNATIONAL COOPERATION; MALE; MULTICENTER STUDIES AS TOPIC; NEEDLE SHARING; ORGANIZATIONAL CASE STUDIES; PROGRAM DEVELOPMENT; QUALITY CONTROL; QUESTIONNAIRES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; WORLD HEALTH ORGANIZATION;

EID: 33646858353     PISSN: 14712458     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-6-54     Document Type: Article

References (11)

1. Musto D: The American Disease: Origins of Narcotic Control. New Haven: Yale University Press; 1973.
2. Aceijas C, Stimson G, Hickman M, Rhodes T: Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004, 18:2295-2303.
3. Des Jarlais DC, Friedman SR: Fifteen years of research on preventing HIV infection among injecting drug users: What we have learned, what we have not learned, what we have done, what we have not done. Public Health Reports 1998, 113:182-188.
4. Stimson GV, Des Jarlais DC, Ball A, (eds): Drug Injecting and HIV Infection: Global Dimensions and Local Responses London: UCL Press; 1998.
5. Des Jarlais DC, Friedmann P, Hagan H, Friedman SR: The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. AJPH 1996, 86:1780-1785.
6. Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A, Ross M, Purchase D, Millson M, Myers T: Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995, 274:1226-1231.
7. World Health Organization: Technical Guide to Rapid Assessment and Response (TG-RAR). [http://www.who.int/hiv/pub/prev_care/tgrar/en/].
8. Fitch C, Stimson GV: An International Review of Rapid Assessments Conducted on Drug Use. A Report from the WHO Drug Injection Study Phase II. 2003 [http://www.who.int/substance_abuse/activities/drug_injecting]. Geneva, World Health Organization
9. Stimson GV, Fitch C, Des Jarlais D, Poznyak V, Perlis T, Oppenheimer E, Rhodes T, for the WHO Phase II Drug Injection Collaborative Study Group: Rapid Assessment and Response Studies of Injection Drug Use: Knowledge Gain, Capacity Building, and Intervention Development in a Multisite Study. Am J Public Health in press.
10. World Health Organization: Drug injection study phase II [http://www.who.int/hiv/pub/prev_care/tgrar/en/11].
11. Council for International Organizations of Medical Sciences (CIOMS): International guidelines for Ethical Review of Epidemiological Studies Geneva: World Health Organization; 1999.